J&J-Good news for vaccinated persons
Admittance to the second Sisonke concentrate being investigated for medical care laborers will start soon, the SA Medical Research Council (SAMRC) and public wellbeing office said. "By carrying out the Sisonke study, we purchased significant time for medical care laborers, and had the option to ensure them four months in front of the public rollout and in front of the Delta-driven third wave," said Prof Glenda Gray, one of the conational head agents of the Sisonke study.
Good news for people who vaccinated
Admittance to the second Sisonke concentrate being investigated for medical care laborers will start soon, the SA Medical Research Council (SAMRC) and public wellbeing division said. "By carrying out the Sisonke study, we purchased significant time for medical services laborers, and had the option to secure them four months in front of the public rollout and in front of the Delta-driven third wave," said Prof Glenda Gray, one of the conational head agents of the Sisonke study.
Good News For Those Who Took The Vaccine, It Will Make The Unvaccinated Want It Too
According to the latest results of a trial involving almost half a million health workers in South Africa, Johnson & Johnson's Covid-19 vaccine reduces the risk of contracting the disease by roughly half. Glenda Gray, co-leader of the study known as Sisonke, said in an interview that the great majority of the breakthrough infections were moderate, citing unpublished data from the trial, which had previously proved the shot's success against severe disease.
Breaking news: sensitive information has been linked about the covid 19 vaccines
https://ewn.co.za/2021/08/06/sa-researchers-provide-first-evidence-j-and-j-jab-is-effective-against-delta-variant SA RESEARCHERS PROVIDE FIRST EVIDENCE J&J JAB IS EFFECTIVE AGAINST DELTA VARIANT Educator Glenda Gray said that the single-shot poke gave assurance of between 91% to 95% against death. CAPE TOWN - South African scientists have given the world's first proof to demonstrate that the Johnson and Johnson COVID-19 immunization was viable against the Delta variation.
Revealed: If You Took The Johnson & Johnson Vaccine, This Will Sh0ck You.
It was revealed that the Johnson and Johnson wants to do a booster trial in South Africa, after the company's first Covid-19 vaccine was used in a mass trial of almost half a million of health workers in South Africa. The trial will include participants from that study, known as Sisonke and could possibly begin in October, according to Glenda Gray, who is co-lead of the mass trial.
Bad news for those who are vaccinated
JOHANNESBURG - A new study carried out through Discovery Health has found that Pfizer COVID-19 jabs supply a discounted protection of about 70% against growing extreme headaches whilst contracting the Omicron version. The same Pfizer double dose gives ninety three% protection towards the Delta variation. The observe started out three months in the past before the Omicron variation become detected however has covered latest facts.
Covid-19 |Attention to people who took J&J vaccine, new informations will leave you in this mood
According to the latest results of a trial involving almost half a million health workers in South Africa, Johnson & Johnson's Covid-19 vaccine reduces the risk of contracting the disease by roughly half. Glenda Gray, co-leader of the study known as Sisonke, said in an interview that the great majority of the breakthrough infections were moderate, citing unpublished data from the trial, which had previously proved the shot's success against severe disease.
The new Omicron Covid Variant is here, Will Ramaphosa Shutdown the Country again?
The head of the South African Medical Research Council has defended South African scientists' decision to reveal the existence of the Covid-19 B1.1.529 variant, despite limited information on it. Professor Glenda Gray said telling the public about the new variant was vital as it might help change behaviour and curb the spread of Covid-19.
Good news to all those who took the Johnson & Johnson vaccine
Johnson and Johnson's Covid-19 immunization cuts the danger of getting contaminated with the infection by about half, as indicated by the most recent aftereffects of a preliminary including practically a large portion of 1,000,000 wellbeing laborers in South Africa. By far most of the advancement diseases were gentle, Glenda Gray, co-head of the examination known as Sisonke, said in a meeting, refering to unpublished information from the preliminary, which had prior shown the shot's adequacy against serious sickness.
If you took the Johnson&Johnson vaccine then here are good news for you
A study of the J&J vaccine which included more than half a million health workers in SA has revealed a good news about the vaccine. This study showed that the J&J vaccine has the ability to cut the risk of being killed by corona virus by half.
Good news: Pfizer jabs work well against Omicron disease
Pfizer antibodies ensure against the Omicron variation of Covid-19, with two portions offering 70% security against admission to the clinic, an enormous true review by Discovery Health and the SA Medical Research Council shows (SAMRC). This is the primary review to show that the danger of hospitalization is lower during the Omicron-driven fourth wave in SA than it has been in past waves, comparative with the quantities of diseases.
Good News if you have taken Johnson & Johnson COVID19 vaccine
Johnson and Johnson's Covid-19 immunization cuts the danger of getting contaminated with the sickness by about half, as indicated by the most recent consequences of a preliminary including practically a large portion of 1,000,000 wellbeing laborers in South Africa. By far most of the advancement diseases were gentle, Glenda Gray, co-head of the investigation known as Sisonke, said in a meeting, refering to unpublished information from the preliminary, which had prior shown the shot's viability against extreme sickness.
Health workers power up Covid-19 defences with J&J booster jabs
Clinical consideration workers organized bit by bit for the current week for a support shot of the J&J Covid-19 immunizer, with around 6,000 getting a second part of the vaccination after it opened up, said Prof Glenda Gray on Friday. The Sisonke 2 audit, driven by Gray and Prof Linda-Gail Bekker, from Wednesday offered clinical consideration workers a support shot of the J&J inoculation before a fourth wave expected for summer.
Revealed | China's Sinovac Has Already Started Testing Covid-19 Vaccines On Children In South Africa
Earlier this week thousands of South Africans on different social media platforms were expressing their outrage after it was reported that China's Sinovac Biotech will start with their Covid-19 vaccine trial on children in South Africa, it was reported that South Africa is amongst five countries that will collectively volunteer 14 000 children aged between six months and 17 years for the trial.
Sisonke study finds J&J COVID-19 vaccine up to 96% effective against death
The Johnson and Johnson Covid-19 antibody is around 91-96% powerful against death and has been observed to be successful against the Delta variation, as indicated by analysts from the Covid-19 Sisonke Implementation Study. Co-head examiner of the examination, Professor Glenda Gray, said the discoveries show that there is "momentous assurance" against Covid-19 hospitalization and passing.
REVEALED: J&J Vaccine Myths Debunked, It Does Not Cause Death
With a slew of bogus news reports about the vaccine circulating, it's critical to set the record straight. A new study has found that the Johnson & Johnson vaccine can protect people from dying or being hospitalized as a result of Covid-19. The Johnson & Johnson vaccination can now protect anyone infected with Covid-19 who has been vaccinated from being hospitalized or, worse, dying, according to the Sisonke program study.
J&J booster shots set to be implemented in South Africa
The SA Medical Research Council is reported to have confirmed that the health workers would be getting their J&J booster shots soom.Prof Glenda Gray is reported to have said that the first round was a success as they managed to protect the health practitioners from hospitalization and deaths related to Covid-19.
Health workers power up Covid-19 defences with J&J booster jabs
Medical care laborers arranged gradually this week for a sponsor shot of the J&J Covid-19 antibody, with around 6,000 getting a second portion of the immunization after it opened up, said Prof Glenda Gray on Friday. The Sisonke 2 review, driven by Gray and Prof Linda-Gail Bekker, from Wednesday offered medical care laborers a sponsor shot of the J&J immunization in front of a fourth wave anticipated for summer.
Study of J&J shot shows Covid-19 infections halved in health workers
Johnson and Johnson's Covid-19 antibody cuts the danger of getting tainted with the sickness by about half, as per the most recent aftereffects of a preliminary including practically a large portion of 1,000,000 wellbeing laborers in South Africa. By far most of the advancement contaminations were gentle, Glenda Gray, co-head of the investigation known as Sisonke, said in a meeting, refering to unpublished information from the preliminary, which had prior shown the shot's adequacy against extreme sickness.
Professor confirms that it is normal to get covid -19 after being vaccinated
Cape Town – While reports have emerged of fully vaccinated people becoming infected with Covid-19, health experts say these cases are to be expected. Speaking during a media briefing on government efforts in the fight against Covid-19 and the national vaccination roll-out program, this morning co-principal investigator of the Sisonke implementation study, Professor Glenda Gray said about 96% of these breakthrough cases are mild.